Skip to main content

Table 2 Frequency of bacteraemia relapse by definitive treatment category

From: Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study

Definitive treatment category Relapse (cases) Non-relapse (controls) Total
Carbapenem 8 (25.8%) 37 (28.9%) 45 (28.3%)
Quinolones 4 (12.9%) 35 (27.3%) 39 (24.5%)
Othera 6 (19.4%) 21 (16.4%) 27 (17.0%)
Piperacillin-tazobactam/ticarcillin-clavulanate 6 (19.4%) 15 (11.7%) 21 (13.2%)
Aminoglycosides 3 (9.7%) 8 (6.2%) 11 (6.9%)
No antibiotic treatment 2 (6.5%) 2 (1.6%) 4 (2.5%)
Trimethoprim/sulphamethoxazole 1 (3.2%) 3 (2.3%) 4 (2.5%)
Cefepime 1 (3.2%) 2 (1.6%) 3 (1.9%)
Ampicillin/amoxicillin 0 (0.0%) 2 (1.6%) 2 (1.3%)
Cephazolin 0 (0.0%) 1 (0.8%) 1 (0.6%)
Ceftriaxone/ceftazidime 0 (0.0%) 1 (0.8%) 1 (0.6%)
Trimethoprim 0 (0.0%) 1 (0.8%) 1 (0.6%)
Total 31 128 159
  1. aIncludes combination therapy